Fibrinolysis and gastrointestinal haemorrhage.
نویسنده
چکیده
Most human tissues contain fibrinolytic activators. The alimentary tract organs, however, were not considered to be a site of importance and were not included in a comprehensive survey of human necropsy tissues studied by Albrechtsen.1 But since Cox, Poller, and Thomson2 found local organ fibrinolysis in the stomach and free plasmin in gastric vein blood there has been much interest in the possible role of fibrinolysis in gastrointestinal bleeding. There is also some evidence that similar influences might contribute to bleeding at other sites in the alimentary tract. complementary studies from other centres using a variety of different techniques and approaches.4-8 In a subsequent study from Manchester9 the fibrinolytic potential of the stomach was found in all subjects. Stimulation was applied to the stomach wall by controlled manipulation at laparotomy. There was a gradation of activity. Fig. 1 shows the shortening of the euglobulin lysis time in serial
منابع مشابه
Pharmacological manipulation of gastric juice: thrombelastographic assessment and implications for treatment of gastrointestinal haemorrhage.
The impairment of formation and maintenance of a formed fibrin clot contributes to the prolonged bleeding and high incidence of rebleeding in upper gastrointestinal haemorrhage. To investigate the basis for the use of drug therapy in gastric bleeding, this study used thrombelastography to determine the effects of pharmacological manipulation of gastric juice on coagulation and fibrinolysis. The...
متن کاملDysfibrinogenaemia associated with a novel heterozygous mutation in FGB (c.680delG) and a mild clinical history of bleeding.
Fibrinogen is a hexameric protein composed of Aa, Bb and g chain pairs [1] encoded by three paralogous genes, FGA, FGB and FGG [2]. Fibrinogen variants are the consequence of mutations in FGA, FGB or FGG and may result in afibrinogenaemia, hypofibrinogenaemia, dysfibrinogenaemia or hypodysfibrinogenaemia. Dysfibrinogenaemia is characterized by a fibrinogen structural abnormality responsible for...
متن کاملFibrinolysis of experimental subretinal haemorrhage without removal using tissue plasminogen activator.
AIMS/BACKGROUND Human recombinant tissue plasminogen activator (rt-PA) fibrinolysis of subretinal haemorrhage with concomitant removal has been shown to reverse the natural history of photoreceptor degeneration in experimental subretinal haemorrhages if evacuated within 7 days. The aim of the study was to determine whether fibrinolysis of subretinal haemorrhage without concomitant removal would...
متن کاملInternational Journal of Pharma and Bio Sciences V1(1)2010 Evaluation of potato tuber carboxypeptidase inhibitor with standard anti-thrombotic drugs in various thrombosis models
Thrombosis is one of the major causes of death worldwide. It occurs due to imbalance between prothrombotic and fibrinolytic pathway. The clot formation activates the endogenous fibrinolytic system, for conversion of plasminogen to plasmin. Plasmin degrades the fibrin clot, restoring blood flow to vital organs. Thus, fibrinolysis is a physiological mechanism designed to remove intravascular thro...
متن کاملCentral nervous system haemorrhage causing early death in acute promyelocytic leukaemia.
Acute promyelocytic leukaemia (APL) is a rare type of paediatric leukaemia characterised by a specific genetic mutation and life-threatening coagulopathy. The discovery of all-trans retinoic acid (ATRA), which acts directly on promyelocytic locus-retinoic acid receptor α (PML-RARα) gene product, brought a revolution to the therapy of this disorder. Unfortunately, despite an improvement in the c...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Journal of clinical pathology. Supplement
دوره 14 شماره
صفحات -
تاریخ انتشار 1980